university website

C.N. de Jong (Cornelis), E. Meijer (Ellen), K. Bakunina (Katerina), E. Nur (Erfan), M. Van Marwijk Kooij (Marinus), M. de Groot (Marco), M. van Gelder (M.), J. Maertens (Johan), J. Kuball (Jürgen), Deeren, D. (Dries), et al. B. van der Holt (Bronno), J.J. Cornelissen (Jan) and A.E.C. Broers (Annoek)

2019-11-13

Post-Transplantation Cyclophosphamide after Allogeneic Hematopoietic Stem Cell Transplantation

Publication

Publication

Results of the Prospective Randomized HOVON-96 Trial in Recipients of Matched Related and Unrelated Donors

Blood , Volume 134 - Issue 1 p. 1

DISCLOSURES: Nur: Novartis Pharmaceuticals: Consultancy. Maertens:Cidara: Other: Personal fees and non-financial support; Gilead Sciences: Other: Grants, personal fees and non-financial support; Amplyx: Other: Personal fees and non-financial support; Merck: Other: Personal fees and non-financial support; Pfizer: Other: Grant and personal fees; Astellas Pharma: Other: Personal fees and non-financial support; F2G: Other: Personal fees and non-financial support. Deeren:Alexion, Amgen, Janssen, Roche, Sunesis, Takeda, Sanofi: Consultancy, Honoraria, Membership on an entity's Board of Directors or advisory committees, Research Funding.

Additional Metadata
Persistent URL doi.org/10.1182/blood-2019-124659, hdl.handle.net/1765/121593
Journal Blood
Rights no subscription
Citation
de Jong, C., Meijer, E., Bakunina, K., Nur, E., Van Marwijk Kooij, M., de Groot, M., … Broers, A. (2019). Post-Transplantation Cyclophosphamide after Allogeneic Hematopoietic Stem Cell Transplantation. Blood, 134(1). doi:10.1182/blood-2019-124659


User Publication Person Organisation Collection
Close